{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:35:03Z","timestamp":1784907303317,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s40618-019-01094-7","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T09:29:19Z","timestamp":1565602159000},"page":"157-162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The clinical phenotype of Graves\u2019 disease occurring as an isolated condition or in association with other autoimmune diseases"],"prefix":"10.1007","volume":"43","author":[{"given":"M.","family":"Rotondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Virili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Coperchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Brusca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Centanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Chiovato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"issue":"24","key":"1094_CR1","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1056\/NEJMcp0801880","volume":"358","author":"GA Brent","year":"2008","unstructured":"Brent GA (2008) Clinical practice. Graves\u2019 disease. N Engl J Med 358(24):2594\u20132605. \nhttps:\/\/doi.org\/10.1056\/NEJMcp0801880","journal-title":"N Engl J Med"},{"issue":"17","key":"1094_CR2","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","volume":"343","author":"AP Weetman","year":"2000","unstructured":"Weetman AP (2000) Graves\u2019 disease. N Engl J Med 343(17):1236\u20131248. \nhttps:\/\/doi.org\/10.1056\/NEJM200010263431707","journal-title":"N Engl J Med"},{"issue":"12","key":"1094_CR3","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/nrendo.2013.193","volume":"9","author":"L Bartalena","year":"2013","unstructured":"Bartalena L (2013) Diagnosis and management of Graves disease: a global overview. Nat Rev Endocrinol 9(12):724\u2013734. \nhttps:\/\/doi.org\/10.1038\/nrendo.2013.193","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"1094_CR4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s40618-014-0097-2","volume":"37","author":"L Bartalena","year":"2014","unstructured":"Bartalena L, Fatourechi V (2014) Extrathyroidal manifestations of Graves\u2019 disease: a 2014 update. J Endocrinol Invest 37(8):691\u2013700. \nhttps:\/\/doi.org\/10.1007\/s40618-014-0097-2","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"1094_CR5","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s40618-016-0516-7","volume":"39","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Masiello E, Magri F et al (2016) The phenotype of newly diagnosed Graves\u2019 disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study. J Endocrinol Invest 39(12):1445\u20131451. \nhttps:\/\/doi.org\/10.1007\/s40618-016-0516-7","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"1094_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1530\/EJE-16-0986","volume":"176","author":"T Struja","year":"2017","unstructured":"Struja T, Kaeslin M, Boesiger F et al (2017) External validation of the GREAT score to predict relapse risk in Graves\u2019 disease: results from a multicenter, retrospective study with 741 patients. Eur J Endocrinol 176(4):413\u2013419. \nhttps:\/\/doi.org\/10.1530\/EJE-16-0986","journal-title":"Eur J Endocrinol"},{"key":"1094_CR7","doi-asserted-by":"publisher","first-page":"3813540","DOI":"10.1155\/2017\/3813540","volume":"2017","author":"J Liu","year":"2017","unstructured":"Liu J, Fu J, Xu Y, Wang G (2017) Antithyroid drug therapy for Graves\u2019 disease and implications for recurrence. Int J Endocrinol 2017:3813540. \nhttps:\/\/doi.org\/10.1155\/2017\/3813540","journal-title":"Int J Endocrinol"},{"issue":"3","key":"1094_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40618-014-0214-2","volume":"38","author":"M Marin\u00f2","year":"2015","unstructured":"Marin\u00f2 M, Latrofa F, Menconi F, Chiovato L, Vitti P (2015) Role of genetic and non-genetic factors in the etiology of Graves\u2019 disease. J Endocrinol Invest 38(3):283\u2013294. \nhttps:\/\/doi.org\/10.1007\/s40618-014-0214-2","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"1094_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1530\/EJE-17-1063","volume":"178","author":"M Rotondi","year":"2018","unstructured":"Rotondi M, Capelli V, Coperchini F et al (2018) Post-partum and non-post-partum relapsing Graves\u2019 hyperthyroidism display different response to anti-thyroid drugs. Eur J Endocrinol 178(6):589\u2013594. \nhttps:\/\/doi.org\/10.1530\/EJE-17-1063","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"1094_CR10","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1210\/jc.2008-0966","volume":"93","author":"M Rotondi","year":"2008","unstructured":"Rotondi M, Cappelli C, Pirali B et al (2008) The effect of pregnancy on subsequent relapse from Graves\u2019 disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab 93(10):3985\u20133988. \nhttps:\/\/doi.org\/10.1210\/jc.2008-0966","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1094_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3928\/0090-4481-19800401-07","volume":"9","author":"M Neufeld","year":"1980","unstructured":"Neufeld M, Maclaren N, Blizzard R (1980) Autoimmune polyglandular syndromes. Pediatr Ann 9(4):154\u2013162","journal-title":"Pediatr Ann"},{"issue":"26","key":"1094_CR12","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1056\/NEJMc1805308","volume":"378","author":"ES Husebye","year":"2018","unstructured":"Husebye ES, Anderson MS, K\u00e4mpe O (2018) Autoimmune polyendocrine syndromes. N Engl J Med 378(26):2543\u20132544. \nhttps:\/\/doi.org\/10.1056\/NEJMc1805308","journal-title":"N Engl J Med"},{"issue":"2","key":"1094_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1530\/EJE-16-0737","volume":"176","author":"RM Ruggeri","year":"2017","unstructured":"Ruggeri RM, Trimarchi F, Giuffrida G et al (2017) Autoimmune comorbidities in Hashimoto\u2019s thyroiditis: different patterns of association in adulthood and childhood\/adolescence. Eur J Endocrinol 176(2):133\u2013141. \nhttps:\/\/doi.org\/10.1530\/EJE-16-0737","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1094_CR14","doi-asserted-by":"publisher","first-page":"183.e181","DOI":"10.1016\/j.amjmed.2009.06.030","volume":"123","author":"K Boelaert","year":"2010","unstructured":"Boelaert K, Newby PR, Simmonds MJ et al (2010) Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med 123(2):183.e181\u2013183.e189. \nhttps:\/\/doi.org\/10.1016\/j.amjmed.2009.06.030","journal-title":"Am J Med"},{"issue":"3","key":"1094_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.autrev.2018.10.001","volume":"18","author":"SM Ferrari","year":"2019","unstructured":"Ferrari SM, Fallahi P, Ruffilli I et al (2019) The association of other autoimmune diseases in patients with Graves\u2019 disease (with or without ophthalmopathy): review of the literature and report of a large series. Autoimmun Rev 18(3):287\u2013292. \nhttps:\/\/doi.org\/10.1016\/j.autrev.2018.10.001","journal-title":"Autoimmun Rev"},{"issue":"9","key":"1094_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrgastro.2013.101","volume":"10","author":"WL Neumann","year":"2013","unstructured":"Neumann WL, Coss E, Rugge M, Genta RM (2013) Autoimmune atrophic gastritis\u2013pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol 10(9):529\u2013541. \nhttps:\/\/doi.org\/10.1038\/nrgastro.2013.101","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"1094_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10067-014-2737-5","volume":"34","author":"RB Mueller","year":"2015","unstructured":"Mueller RB, Schiff M, Kaegi T et al (2015) The new 2010 ACR\/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis. Clin Rheumatol 34(1):51\u201359. \nhttps:\/\/doi.org\/10.1007\/s10067-014-2737-5","journal-title":"Clin Rheumatol"},{"key":"1094_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jaut.2014.01.019","volume":"48\u201349","author":"M Mosca","year":"2014","unstructured":"Mosca M, Tani C, Vagnani S, Carli L, Bombardieri S (2014) The diagnosis and classification of undifferentiated connective tissue diseases. J Autoimmun 48\u201349:50\u201352. \nhttps:\/\/doi.org\/10.1016\/j.jaut.2014.01.019","journal-title":"J Autoimmun"},{"issue":"1","key":"1094_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","volume":"20","author":"A Ta\u00efeb","year":"2007","unstructured":"Ta\u00efeb A, Picardo M, Members V (2007) The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 20(1):27\u201335. \nhttps:\/\/doi.org\/10.1111\/j.1600-0749.2006.00355.x","journal-title":"Pigment Cell Res"},{"issue":"2","key":"1094_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/MCG.0b013e31827a6f83","volume":"47","author":"JC Bai","year":"2013","unstructured":"Bai JC, Fried M, Corazza GR et al (2013) World Gastroenterology Organisation global guidelines on celiac disease. J Clin Gastroenterol 47(2):121\u2013126. \nhttps:\/\/doi.org\/10.1097\/MCG.0b013e31827a6f83","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"1094_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295\u2013306. \nhttps:\/\/doi.org\/10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thromb Haemost"},{"issue":"10","key":"1094_CR22","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1089\/thy.2008.1551","volume":"18","author":"M Ludgate","year":"2008","unstructured":"Ludgate M, Emerson CH (2008) Metamorphic thyroid autoimmunity. Thyroid 18(10):1035\u20131037. \nhttps:\/\/doi.org\/10.1089\/thy.2008.1551","journal-title":"Thyroid"},{"issue":"5","key":"1094_CR23","first-page":"185","volume":"55","author":"C Osorio-Salazar","year":"1994","unstructured":"Osorio-Salazar C, Lecomte P, Madec AM, Baulieu JL (1994) Basedow disease following autoimmune primary hypothyroidism. Apropos of 7 cases. Ann Endocrinol (Paris) 55(5):185\u2013189","journal-title":"Ann Endocrinol (Paris)"},{"issue":"3","key":"1094_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1365-2265.2012.04397.x","volume":"77","author":"C Kamath","year":"2012","unstructured":"Kamath C, Young S, Kabelis K et al (2012) Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto\u2019s who developed Graves\u2019 disease and pretibial myxoedema. Clin Endocrinol (Oxf) 77(3):465\u2013470. \nhttps:\/\/doi.org\/10.1111\/j.1365-2265.2012.04397.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1094_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1365-2265.1988.tb03664.x","volume":"28","author":"K Takeda","year":"1988","unstructured":"Takeda K, Takamatsu J, Kasagi K et al (1988) Development of hyperthyroidism following primary hypothyroidism: a case report with changes in thyroid-related antibodies. Clin Endocrinol (Oxf) 28(4):341\u2013344","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1094_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S1607-551X(09)70105-6","volume":"20","author":"YH Chung","year":"2004","unstructured":"Chung YH, Ou HY, Wu TJ (2004) Development of hyperthyroidism following primary hypothyroidism: a case report. Kaohsiung J Med Sci 20(4):188\u2013191. \nhttps:\/\/doi.org\/10.1016\/S1607-551X(09)70105-6","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"1094_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1089\/thy.2012.0374","volume":"23","author":"SM McLachlan","year":"2013","unstructured":"McLachlan SM, Rapoport B (2013) Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid 23(1):14\u201324. \nhttps:\/\/doi.org\/10.1089\/thy.2012.0374","journal-title":"Thyroid"},{"issue":"10","key":"1094_CR28","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1089\/thy.2008.0142","volume":"18","author":"B Champion","year":"2008","unstructured":"Champion B, Gopinath B, Ma G, El-Kaissi S, Wall JR (2008) Conversion to Graves\u2019 hyperthyroidism in a patient with hypothyroidism due to Hashimoto\u2019s thyroiditis documented by real-time thyroid ultrasonography. Thyroid 18(10):1135\u20131137. \nhttps:\/\/doi.org\/10.1089\/thy.2008.0142","journal-title":"Thyroid"},{"key":"1094_CR29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/1756-0500-7-489","volume":"7","author":"S Furqan","year":"2014","unstructured":"Furqan S, Haque NU, Islam N (2014) Conversion of autoimmune hypothyroidism to hyperthyroidism. BMC Res Notes 7:489. \nhttps:\/\/doi.org\/10.1186\/1756-0500-7-489","journal-title":"BMC Res Notes"},{"key":"1094_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-006433","author":"Y Gupta","year":"2012","unstructured":"Gupta Y, Singh S, Ammini AC (2012) Development of Graves\u2019 disease after long-standing hypothyroidism on treatment, with acute toxicity to thionamides and lithium. BMJ Case Rep. \nhttps:\/\/doi.org\/10.1136\/bcr-2012-006433","journal-title":"BMJ Case Rep"},{"issue":"4","key":"1094_CR31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/acta.0.1080491","volume":"108","author":"PM Bell","year":"1985","unstructured":"Bell PM, Sinnamon DG, Smyth PP et al (1985) Hyperthyroidism following primary hypothyroidism in association with polyendocrine autoimmunity. Acta Endocrinol (Copenh) 108(4):491\u2013497","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"4","key":"1094_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1530\/acta.0.1200447","volume":"120","author":"BY Cho","year":"1989","unstructured":"Cho BY, Shong YK, Lee HK, Koh CS, Min HK (1989) Graves\u2019 hyperthyroidism following primary hypothyroidism: sequential changes in various activities of thyrotropin receptor antibodies. Acta Endocrinol (Copenh) 120(4):447\u2013450","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"6","key":"1094_CR33","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1365-2265.1990.tb03906.x","volume":"33","author":"N Takasu","year":"1990","unstructured":"Takasu N, Yamada T, Sato A et al (1990) Graves\u2019 disease following hypothyroidism due to Hashimoto\u2019s disease: studies of eight cases. Clin Endocrinol (Oxf) 33(6):687\u2013698","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1094_CR34","doi-asserted-by":"publisher","first-page":"609","DOI":"10.20945\/2359-3997000000086","volume":"62","author":"B Gonzalez-Aguilera","year":"2018","unstructured":"Gonzalez-Aguilera B, Betea D, Lutteri L et al (2018) Conversion to Graves disease from Hashimoto thyroiditis: a study of 24 patients. Arch Endocrinol Metab 62(6):609\u2013614. \nhttps:\/\/doi.org\/10.20945\/2359-3997000000086","journal-title":"Arch Endocrinol Metab"},{"issue":"6","key":"1094_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1159\/000313395","volume":"73","author":"M Wasniewska","year":"2010","unstructured":"Wasniewska M, Corrias A, Arrigo T et al (2010) Frequency of Hashimoto\u2019s thyroiditis antecedents in the history of children and adolescents with graves\u2019 disease. Horm Res Paediatr 73(6):473\u2013476. \nhttps:\/\/doi.org\/10.1159\/000313395","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"1094_CR36","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1089\/thy.2013.0452","volume":"24","author":"T Aversa","year":"2014","unstructured":"Aversa T, Lombardo F, Corrias A, Salerno M, De Luca F, Wasniewska M (2014) In young patients with Turner or Down syndrome, Graves\u2019 disease presentation is often preceded by Hashimoto\u2019s thyroiditis. Thyroid 24(4):744\u2013747. \nhttps:\/\/doi.org\/10.1089\/thy.2013.0452","journal-title":"Thyroid"},{"issue":"2","key":"1094_CR37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1365-2249.2009.03895.x","volume":"156","author":"KH Mortensen","year":"2009","unstructured":"Mortensen KH, Cleemann L, Hjerrild BE et al (2009) Increased prevalence of autoimmunity in Turner syndrome\u2013influence of age. Clin Exp Immunol 156(2):205\u2013210. \nhttps:\/\/doi.org\/10.1111\/j.1365-2249.2009.03895.x","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"1094_CR38","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1365-2249.2012.04610.x","volume":"169","author":"FP Pellegrini","year":"2012","unstructured":"Pellegrini FP, Marinoni M, Frangione V et al (2012) Down syndrome, autoimmunity and T regulatory cells. Clin Exp Immunol 169(3):238\u2013243. \nhttps:\/\/doi.org\/10.1111\/j.1365-2249.2012.04610.x","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"1094_CR39","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1530\/eje.0.1340568","volume":"134","author":"L Chiovato","year":"1996","unstructured":"Chiovato L, Larizza D, Bendinelli G et al (1996) Autoimmune hypothyroidism and hyperthyroidism in patients with Turner\u2019s syndrome. Eur J Endocrinol 134(5):568\u2013575","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"1094_CR40","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1055\/s-0035-1559633","volume":"47","author":"SA Morshed","year":"2015","unstructured":"Morshed SA, Davies TF (2015) Graves\u2019 disease mechanisms: the role of stimulating, blocking, and cleavage region TSH receptor antibodies. Horm Metab Res 47(10):727\u2013734. \nhttps:\/\/doi.org\/10.1055\/s-0035-1559633","journal-title":"Horm Metab Res"},{"issue":"3","key":"1094_CR41","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1365-2265.2010.03831.x","volume":"73","author":"M Evans","year":"2010","unstructured":"Evans M, Sanders J, Tagami T et al (2010) Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample. Clin Endocrinol (Oxf) 73(3):404\u2013412. \nhttps:\/\/doi.org\/10.1111\/j.1365-2265.2010.03831.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1094_CR42","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1210\/jcem.83.1.4492","volume":"83","author":"L Chiovato","year":"1998","unstructured":"Chiovato L, Fiore E, Vitti P et al (1998) Outcome of thyroid function in Graves\u2019 patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. J Clin Endocrinol Metab 83(1):40\u201346. \nhttps:\/\/doi.org\/10.1210\/jcem.83.1.4492","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1094_CR43","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/thy.1993.3.315","volume":"3","author":"K Kasagi","year":"1993","unstructured":"Kasagi K, Hidaka A, Endo K et al (1993) Fluctuating thyroid function depending on the balance between stimulating and blocking types of TSH receptor antibodies: a case report. Thyroid 3(4):315\u2013318. \nhttps:\/\/doi.org\/10.1089\/thy.1993.3.315","journal-title":"Thyroid"},{"issue":"2","key":"1094_CR44","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2265.1992.tb00960.x","volume":"36","author":"Z Kraiem","year":"1992","unstructured":"Kraiem Z, Baron E, Kahana L, Sadeh O, Sheinfeld M (1992) Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper-thyroidism and back to hypothyroidism. Clin Endocrinol (Oxf) 36(2):211\u2013214","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"1094_CR45","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI109601","volume":"64","author":"LC Wood","year":"1979","unstructured":"Wood LC, Ingbar SH (1979) Hypothyroidism as a late sequela in patient with Graves\u2019 disease treated with antithyroid agents. J Clin Invest 64(5):1429\u20131436. \nhttps:\/\/doi.org\/10.1172\/JCI109601","journal-title":"J Clin Invest"},{"issue":"1","key":"1094_CR46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1210\/jcem-69-1-49","volume":"69","author":"H Tamai","year":"1989","unstructured":"Tamai H, Kasagi K, Takaichi Y et al (1989) Development of spontaneous hypothyroidism in patients with Graves\u2019 disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients. J Clin Endocrinol Metab 69(1):49\u201353. \nhttps:\/\/doi.org\/10.1210\/jcem-69-1-49","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1094_CR47","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1001\/archinte.1990.00390170129028","volume":"150","author":"C Shigemasa","year":"1990","unstructured":"Shigemasa C, Mitani Y, Taniguchi S et al (1990) Three patients who spontaneously developed persistent hypothyroidism during or following treatment with antithyroid drugs for Graves\u2019 hyperthyroidism. Arch Intern Med 150(5):1105\u20131109","journal-title":"Arch Intern Med"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-019-01094-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-019-01094-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-019-01094-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T23:11:52Z","timestamp":1597101112000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-019-01094-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,12]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1094"],"URL":"https:\/\/doi.org\/10.1007\/s40618-019-01094-7","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,12]]},"assertion":[{"value":"12 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Formal approval by the ethical committee was not required in accordance with the Italian regulation for non-interventional (observational) retrospective studies concerning human beings (AIFA Guidelines for Observational Studies, see ).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients signed an informed consent concerning the future use of their clinic data for research purposes and data collected remained strictly confidential and anonymous, according to the ethical rules of our Hospital institutions and to the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}